PG - The Procter & Gamble Company
NYSE
->
Consumer Defensive
->
Household & Personal Products
Cincinnati,
United States
Type: Equity
PG price evolution
PG
| (in millions $) | 31 Jan 2025 | 30 Oct 2024 | 30 Jul 2024 | 31 Mar 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $9482 | $6828 | ||
| Short term investments | ||||
| Net receivables | $6118 | $6314 | $6118 | $6124 |
| Inventory | $7016 | $7287 | $7016 | $7077 |
| Total current assets | $24709 | $27449 | $24709 | $22458 |
| Long term investments | ||||
| Property, plant & equipment | $22152 | $22506 | $22152 | $22027 |
| Goodwill & intangible assets | $62350 | $62760 | ||
| Total noncurrent assets | $97661 | $97140 | ||
| Total investments | ||||
| Total assets | $122370 | $126482 | $122370 | $119598 |
| Current liabilities | ||||
| Accounts payable | $15364 | $15350 | $15364 | $13691 |
| Deferred revenue | ||||
| Short long term debt | $7191 | $7729 | ||
| Total current liabilities | $33627 | $36420 | $33627 | $32340 |
| Long term debt | $25269 | $25744 | $25269 | $24253 |
| Total noncurrent liabilities | $38184 | $36924 | ||
| Total debt | $32460 | $31982 | ||
| Total liabilities | $71811 | $74641 | $71811 | $69264 |
| Shareholders' equity | ||||
| Retained earnings | $125361 | $123811 | $123132 | |
| Other shareholder equity | $50559 | -$11611 | -$11900 | -$12370 |
| Total shareholder equity | $50287 | $50058 | ||
| (in millions $) | 31 Jan 2025 | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $9482 | $8246 | $7214 | $10288 |
| Short term investments | ||||
| Net receivables | $6118 | $5471 | $5143 | $4725 |
| Inventory | $7016 | $7073 | $6924 | $5983 |
| Total current assets | $24709 | $22648 | $21653 | $23091 |
| Long term investments | ||||
| Property, plant & equipment | $22152 | $21909 | $21195 | $21686 |
| Goodwill & intangible assets | $62350 | $64442 | $63379 | $64566 |
| Total noncurrent assets | $97661 | $98181 | $95555 | $96216 |
| Total investments | ||||
| Total assets | $122370 | $120829 | $117208 | $119307 |
| Current liabilities | ||||
| Accounts payable | $15364 | $14598 | $14882 | $13720 |
| Deferred revenue | ||||
| Short long term debt | $7191 | $10229 | $8645 | $8889 |
| Total current liabilities | $33627 | $35756 | $33081 | $33132 |
| Long term debt | $25269 | $24378 | $22848 | $23099 |
| Total noncurrent liabilities | $38184 | $38008 | $37273 | $39521 |
| Total debt | $32460 | $34607 | $31493 | $31988 |
| Total liabilities | $71811 | $73764 | $70354 | $72653 |
| Shareholders' equity | ||||
| Retained earnings | $123811 | $118170 | $112429 | $106374 |
| Other shareholder equity | $50559 | -$12220 | -$12189 | -$13744 |
| Total shareholder equity | $50287 | $47065 | $46854 | $46654 |
| (in millions $) | 1 May 2025 | 31 Jan 2025 | 30 Oct 2024 | 30 Jul 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $21737 | |||
| Cost of revenue | ||||
| Gross Profit | $11357 | |||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $5465 | |||
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $1152 | |||
| Interest expense | -$103 | |||
| Net income | ||||
| Net income | $3887 | |||
| Income (for common shares) | ||||
| (in millions $) | 31 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 | 31 Jan 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $84039 | $82006 | $80187 | $76118 |
| Cost of revenue | $40848 | $42760 | $42157 | $37108 |
| Gross Profit | $43191 | $39246 | $38030 | $39010 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $23305 | $21112 | $20217 | $21024 |
| Total operating expenses | $24646 | $21112 | $20217 | $21024 |
| Operating income | $18545 | $18134 | $17813 | $17986 |
| Income from continuing operations | ||||
| EBIT | $19591 | $19024 | $18383 | $18071 |
| Income tax expense | $3787 | $3615 | $3202 | $3263 |
| Interest expense | $925 | $756 | $439 | $502 |
| Net income | ||||
| Net income | $14879 | $14653 | $14742 | $14306 |
| Income (for common shares) | $14879 | $14653 | $14742 | $14306 |
| (in millions $) | 31 Jan 2025 | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 |
|---|---|---|---|---|
| Net income | $3137 | $3754 | ||
| Operating activities | ||||
| Depreciation | $761 | $712 | ||
| Business acquisitions & disposals | -$21 | |||
| Stock-based compensation | $129 | $158 | ||
| Total cash flows from operations | $5754 | $4088 | ||
| Investing activities | ||||
| Capital expenditures | -$783 | -$797 | ||
| Investments | ||||
| Total cash flows from investing | -$3504 | -$1108 | -$518 | -$762 |
| Financing activities | ||||
| Dividends paid | -$9312 | -$2445 | -$2449 | -$2285 |
| Sale and purchase of stock | -$576 | -$419 | ||
| Net borrowings | $526 | -$1563 | ||
| Total cash flows from financing | -$14855 | -$634 | -$2499 | -$4269 |
| Effect of exchange rate | -$251 | $116 | -$83 | -$119 |
| Change in cash and equivalents | $1235 | $2675 | $2653 | -$1062 |
| (in millions $) | 31 Jan 2025 | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Net income | $14653 | $14742 | $14306 | |
| Operating activities | ||||
| Depreciation | $2714 | $2807 | $2735 | |
| Business acquisitions & disposals | -$765 | -$1381 | -$34 | |
| Stock-based compensation | $545 | $528 | $540 | |
| Total cash flows from operations | $16848 | $16723 | $18371 | |
| Investing activities | ||||
| Capital expenditures | -$3062 | -$3156 | -$2787 | |
| Investments | $3 | -$55 | ||
| Total cash flows from investing | -$3504 | -$3500 | -$4424 | -$2834 |
| Financing activities | ||||
| Dividends paid | -$9312 | -$8999 | -$8770 | -$8263 |
| Sale and purchase of stock | -$6084 | -$7998 | -$9365 | |
| Net borrowings | $2937 | $1892 | -$3903 | |
| Total cash flows from financing | -$14855 | -$12146 | -$14876 | -$21531 |
| Effect of exchange rate | -$251 | -$170 | -$497 | $101 |
| Change in cash and equivalents | $1235 | $1032 | -$3074 | -$5893 |
News
Fundamentals
| Market cap | $407.19B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 2.36B |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 1.43 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 0.73 |
| Quick ratio | 0.53 |